Tech Company Financing Transactions
Delphinus Medical Technologies Funding Round
Arboretum Ventures, Beringea and Hopen Life Science Ventures participated in a $30 million Series D funding round for Delphinus Medical Technologies. The round was announced on 9/29/2022.
Transaction Overview
Company Name
Announced On
9/29/2022
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
Proceeds Purpose
Our series D will support the robust commercial strategies and efforts needed to help sites quickly adopt this solution for their patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
45525 Grand River Ave.
Novi, MI 48374
USA
Novi, MI 48374
USA
Phone
Website
Email Address
Not Recorded
Overview
Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Forchette
Chief Financial Officer
Shawn O'Brien
Chief Technical Officer
Neb Duric
Co-Founder
Peter Littrup
VP - Engineering
Bruno Dacquay
VP - Regulatory Affairs
Heather Rone
VP - Sales
Debra Saunders
Browse more venture capital transactions:
Prev: 9/29/2022: Meliora Therapeutics venture capital transaction
Next: 9/29/2022: RoboSense venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs